225 related articles for article (PubMed ID: 17332620)
21. Preclinical evaluation of a high-affinity 18F-trifluoroborate octreotate derivative for somatostatin receptor imaging.
Liu Z; Pourghiasian M; Bénard F; Pan J; Lin KS; Perrin DM
J Nucl Med; 2014 Sep; 55(9):1499-505. PubMed ID: 24970911
[TBL] [Abstract][Full Text] [Related]
22. Micro-PET imaging of [18F]fluoroacetate combined with [18F]FDG to differentiate chronic Mycobacterium tuberculosis infection from an acute bacterial infection in a mouse model: a preliminary study.
Tsao CH; Wu CY; Chang CW; Wang HE; Shih BF; Liu RS
Nucl Med Commun; 2019 Jun; 40(6):639-644. PubMed ID: 30932968
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer.
Kwan KH; Burvenich IJG; Centenera MM; Goh YW; Rigopoulos A; Dehairs J; Swinnen JV; Raj GV; Hoy AJ; Butler LM; Scott AM; White JM; Ackermann U
Nucl Med Biol; 2021 Feb; 93():37-45. PubMed ID: 33310350
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo characterization of 2-deoxy-2-18F-fluoro-D-mannose as a tumor-imaging agent for PET.
Furumoto S; Shinbo R; Iwata R; Ishikawa Y; Yanai K; Yoshioka T; Fukuda H
J Nucl Med; 2013 Aug; 54(8):1354-61. PubMed ID: 23843565
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of trans-9-18F-fluoro-3,4-Methyleneheptadecanoic acid as a PET tracer for myocardial fatty acid imaging.
Shoup TM; Elmaleh DR; Bonab AA; Fischman AJ
J Nucl Med; 2005 Feb; 46(2):297-304. PubMed ID: 15695790
[TBL] [Abstract][Full Text] [Related]
26. PET imaging of prostate tumors with 18F-Al-NOTA-MATBBN.
Pan D; Yan Y; Yang R; Xu YP; Chen F; Wang L; Luo S; Yang M
Contrast Media Mol Imaging; 2014; 9(5):342-8. PubMed ID: 24729577
[TBL] [Abstract][Full Text] [Related]
27. Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging.
Hara T; Kosaka N; Kishi H
J Nucl Med; 2002 Feb; 43(2):187-99. PubMed ID: 11850483
[TBL] [Abstract][Full Text] [Related]
28. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X
Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377
[TBL] [Abstract][Full Text] [Related]
29. A preliminary study of anti-1-amino-3-18F-fluorocyclobutyl-1-carboxylic acid for the detection of prostate cancer.
Oka S; Hattori R; Kurosaki F; Toyama M; Williams LA; Yu W; Votaw JR; Yoshida Y; Goodman MM; Ito O
J Nucl Med; 2007 Jan; 48(1):46-55. PubMed ID: 17204698
[TBL] [Abstract][Full Text] [Related]
30. Radiation dosimetry estimates of [18F]-fluoroacetate based on biodistribution data of rats.
Zhang JP; Zhang YJ; Xu JY; Yang ZY
Appl Radiat Isot; 2012 Jan; 70(1):332-5. PubMed ID: 22019094
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of [11C]hemicholinium-15 and [18F]hemicholinium-15 as new potential PET tracers for the high-affinity choline uptake system in the heart.
Gao M; Miller MA; DeGrado TR; Mock BH; Lopshire JC; Rosenberger JG; Dusa C; Das MK; Groh WJ; Zipes DP; Hutchins GD; Zheng QH
Bioorg Med Chem; 2007 Feb; 15(3):1289-97. PubMed ID: 17116396
[TBL] [Abstract][Full Text] [Related]
32. [11C]Choline as a PET biomarker for assessment of prostate cancer tumor models.
Zheng QH; Gardner TA; Raikwar S; Kao C; Stone KL; Martinez TD; Mock BH; Fei X; Wang JQ; Hutchins GD
Bioorg Med Chem; 2004 Jun; 12(11):2887-93. PubMed ID: 15142549
[TBL] [Abstract][Full Text] [Related]
33. Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII.
Nielsen CH; Erlandsson M; Jeppesen TE; Jensen MM; Kristensen LK; Madsen J; Petersen LC; Kjaer A
J Nucl Med; 2016 Jan; 57(1):89-95. PubMed ID: 26383146
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.
DeGrado TR; Coleman RE; Wang S; Baldwin SW; Orr MD; Robertson CN; Polascik TJ; Price DT
Cancer Res; 2001 Jan; 61(1):110-7. PubMed ID: 11196147
[TBL] [Abstract][Full Text] [Related]
35. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS
J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066
[TBL] [Abstract][Full Text] [Related]
36. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
Shiue GG; Choi SR; Fang P; Hou C; Acton PD; Cardi C; Saffer JR; Greenberg JH; Karp JS; Kung HF; Shiue CY
J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
[TBL] [Abstract][Full Text] [Related]
37. N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer.
Mease RC; Dusich CL; Foss CA; Ravert HT; Dannals RF; Seidel J; Prideaux A; Fox JJ; Sgouros G; Kozikowski AP; Pomper MG
Clin Cancer Res; 2008 May; 14(10):3036-43. PubMed ID: 18483369
[TBL] [Abstract][Full Text] [Related]
38. Grading of brain glioma with 1-11C-acetate PET: comparison with 18F-FDG PET.
Tsuchida T; Takeuchi H; Okazawa H; Tsujikawa T; Fujibayashi Y
Nucl Med Biol; 2008 Feb; 35(2):171-6. PubMed ID: 18312826
[TBL] [Abstract][Full Text] [Related]
39. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.
Price DT; Coleman RE; Liao RP; Robertson CN; Polascik TJ; DeGrado TR
J Urol; 2002 Jul; 168(1):273-80. PubMed ID: 12050555
[TBL] [Abstract][Full Text] [Related]
40. 1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer.
Vāvere AL; Kridel SJ; Wheeler FB; Lewis JS
J Nucl Med; 2008 Feb; 49(2):327-34. PubMed ID: 18199615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
